Please provide your email address to receive an email when new articles are posted on . The authors reported that both propensity score matching and propensity score weighting distinguish between the ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma. This is an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results